Answer
Quofenix (delafloxacin meglumine) treats acute bacterial skin and skin structure infections and community-acquired pneumonia in adults, only when commonly recommended antibiotics are inappropriate because of resistance, contraindications, side effects requiring treatment cessation or treatment failure, with consideration of official antibacterial guidance.
Sources for this answer
- Quofenix 300 mg powder for concentrate for solution for infusionA. Menarini Farmaceutica Internazionale SRL · emc · SmPC §4.1 Therapeutic Indications · Version 9Document updated
Sources checked